RxSIGHT, INC.(RXST)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RXST RxSIGHT, INC.

交易中 07-23 12:11:09 EDT

5.28

-0.11

-2.04%

最高5.41	最低5.25	成交量29.29万
今开5.28	昨收5.39	日振幅3.06%
总市值2.19亿	流通市值2.04亿	总股本4,140万
成交额155.66万	换手率0.76%	流通股本3,873万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RXST","market":"US","secType":"STK","nameCN":"RxSIGHT, INC.","latestPrice":5.28,"timestamp":1784823067286,"preClose":5.39,"halted":0,"volume":292884,"delay":0,"changeRate":-0.020408163265306017,"floatShares":38726395,"shares":41396609,"eps":-1.13613,"marketStatus":"交易中","change":-0.11,"latestTime":"07-23 12:11:09 EDT","open":5.28,"high":5.41,"low":5.245,"amount":1556564.6452776,"amplitude":0.030612,"askPrice":5.29,"askSize":200,"bidPrice":5.28,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.13613,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784836800000},"marketStatusCode":2,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":5.39,"preHourTrading":{"tag":"盘前","latestPrice":5.29,"preClose":5.39,"latestTime":"09:29 EDT","volume":389,"amount":2054.0699595,"timestamp":1784813399999,"change":-0.1,"changeRate":-0.018553,"amplitude":0.165121},"postHourTrading":{"tag":"盘后","latestPrice":5.44,"preClose":5.39,"latestTime":"19:34 EDT","volume":40688,"amount":219324.06,"timestamp":1784763248566,"change":0.05,"changeRate":0.009276,"amplitude":0.009276},"volumeRatio":0.558239,"impliedVol":0.5289,"impliedVolPercentile":0.1713},"requestUrl":"/m/hq/s/RXST/wiki","defaultTab":"wiki","newsList":[{"id":"1144277258","title":"RxSIGHT宣布任命Aziz Mottiwala为首席执行官，Ron Kurtz博士为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1144277258","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144277258?lang=zh_cn&edition=full","pubTime":"2026-07-16 04:16","pubTimestamp":1784146582,"startTime":"0","endTime":"0","summary":"RxSIGHT公司宣布了其领导层的重要人事任命。Aziz Mottiwala已被任命为公司的首席执行官，而Ron Kurtz博士则获任首席医疗官一职。\n此次任命旨在加强公司的战略领导与临床医学专业能力。Mottiwala先生将负责公司的整体运营与战略方向，而Kurtz博士将专注于医疗事务、临床开发及科学战略。\n公司期待在新的领导团队带领下，继续推进其在眼科医疗技术领域的创新与发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXST","BK4539","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163592945","title":"RxSIGHT公司重申：本次公告不更新此前发布的财务指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1163592945","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163592945?lang=zh_cn&edition=full","pubTime":"2026-07-16 04:16","pubTimestamp":1784146572,"startTime":"0","endTime":"0","summary":"RxSIGHT公司明确表示，本次公告内容不涉及对先前已公布的财务指导进行任何更新或调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXST","BK4539","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128826267","title":"RxSIGHT, INC. 公布第二季度初步财务业绩及达成战略合作后的产品管线更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128826267","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128826267?lang=zh_cn&edition=full","pubTime":"2026-07-07 04:17","pubTimestamp":1783369034,"startTime":"0","endTime":"0","summary":"RxSIGHT, INC. 披露了其第二季度的初步财务数据，并同步更新了在达成一项战略合作协议后，公司产品管线的进展情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4539","RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618243446","title":"Rxsight, Inc.盘中异动 快速下跌6.50%报7.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618243446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618243446?lang=zh_cn&edition=full","pubTime":"2026-03-09 21:30","pubTimestamp":1773063025,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日21时30分，Rxsight, Inc.股票出现波动，股价快速下挫6.50%。截至发稿，该股报7.19美元/股，成交量5.8761万股，换手率0.14%，振幅0.91%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。Rxsight, Inc.公司简介：RxSight Inc 是一家处于商业化阶段的医疗技术公司，致力于改善白内障术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030921302695461696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030921302695461696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4539","RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516687806","title":"Rxsight, Inc.盘中异动 下午盘急速下挫5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516687806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516687806?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:25","pubTimestamp":1741033521,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时25分，Rxsight, Inc.股票出现波动，股价快速下挫5.29%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.92%。其相关个股中，Adagio Medical Holdings, Inc、Senseonics Holdings, Inc.、Ceribell, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为50.36%、18.83%、12.78%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040425219637fb37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503040425219637fb37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516552785","title":"Rxsight, Inc.2024财年实现净利润-27.46百万美元，同比增加43.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552785?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844878,"startTime":"0","endTime":"0","summary":"3月2日，Rxsight, Inc.公布财报，公告显示公司2024财年净利润为-27.46百万美元，同比增加43.51%；其中营业收入为1.40亿美元，同比增加57.16%，每股基本收益为-0.71美元。从资产负债表来看，Rxsight, Inc.总负债37.33百万美元，其中短期债务974000.00美元，资产负债比为0.09，流动比率为0.12。机构评级：截至2025年3月2日，当前有10家机构对Rxsight, Inc.目标价做出预测，其中目标均价为44.80美元，其中最低目标价为33.00美元，最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000212abe2c625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000212abe2c625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113282974","title":"异动解读 | RxSIGHT盘中大跌7.48%,富国银行下调目标价引发长期前景担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1113282974","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113282974?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:28","pubTimestamp":1740583719,"startTime":"0","endTime":"0","summary":"医疗技术公司RxSIGHT, INC.(RXST)今日出现大幅下跌,其股价盘中一度狂跌7.48%,引发市场广泛关注。\n此前,富国银行维持了对RXST的\"持股观望\"评级,但将其目标股价从40美元下调至35美元。这一分析机构调整目标价的行动,或引发了投资者对公司长期前景的担忧,促使股价下滑。\n另外,盘中RXST股价一度飙升后随后大幅波动下跌,最大跌幅超过6%,也可能引发了一定程度的恐慌性抛售,导致该股出现大跌行情。尽管在今天盘后该股有所反弹,但仍未能收复全部跌幅。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | RxSIGHT盘中大跌7.48%,富国银行下调目标价引发长期前景担忧","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514851000","title":"Rxsight, Inc.盘中异动 早盘急速跳水6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851000?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:30","pubTimestamp":1740580204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时30分，Rxsight, Inc.股票出现波动，股价快速下挫6.06%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Nuwellis, Inc.、Zomedica Corp.、Zimvie Inc.涨幅较大，Biomerica, Inc.、Venus Concept Inc.、Reshape Lifesciences, Inc.较为活跃，换手率分别为8.68%、7.03%、4.68%，振幅较大的相关个股有Myomo Inc.、Zomedica Corp.、Zimvie Inc.，振幅分别为0.20%、0.00%、0.00%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622300596314ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022622300596314ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4539","RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514385591","title":"富国银行：维持RxSight(RXST.US)评级，由持股观望调整至持股观望评级, 目标价由40.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385591","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385591?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:15","pubTimestamp":1740579310,"startTime":"0","endTime":"0","summary":"富国银行：维持RxSight(RXST.US)评级，由持股观望调整至持股观望评级, 目标价由40.00美元调整至35.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26221548412684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1182678271","title":"RxSight 2024年第四季度每股收益由$(0.13)提升至$0.03，销售额为$40.214百万，低于预期的$40.318百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1182678271","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182678271?lang=zh_cn&edition=full","pubTime":"2025-02-26 05:48","pubTimestamp":1740520126,"startTime":"0","endTime":"0","summary":"RxSight 报告季度每股收益为$0.03。这比去年同期每股亏损$增长了123.08%。公司报告季度销售额为$40.214百万，低于分析师一致预期的$40.318百万，差距为0.26%。以上内容来自Benzinga Earnings专栏，原文如下：RxSight  reported quarterly earnings of $0.03 per share. This is a 123.08 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $40.214 million which missed the analyst consensus estimate of $40.318 million by 0.26 percent.  This is a 40.71 percent increase over sales of $28.580 million the same period last yea","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"RxSight 2024年第四季度每股收益由$(0.13)提升至$0.03，销售额为$40.214百万，低于预期的$40.318百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512485160","title":"Rxsight, Inc.盘中异动 快速上涨5.95%报31.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512485160?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:26","pubTimestamp":1739899577,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时26分，Rxsight, Inc.股票出现波动，股价大幅拉升5.95%。截至发稿，该股报31.59美元/股，成交量16.348万股，换手率0.41%，振幅4.33%。Rxsight, Inc.股票所在的医疗器械行业中，整体跌幅为0.79%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190126179627b443&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190126179627b443&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511269757","title":"Rxsight, Inc.盘中异动 快速下挫5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511269757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511269757?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:20","pubTimestamp":1739550035,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时20分，Rxsight, Inc.股票出现波动，股价大幅下挫5.05%。Rxsight, Inc.股票所在的医疗器械行业中，整体跌幅为0.28%。其相关个股中，Avita Medical, Inc.、Pacific Biosciences Of California, Inc.、Outset Medical, Inc.涨幅较大，Nanovibronix, Inc.、Tivic Health Systems, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为214.20%、58.17%、11.27%，振幅较大的相关个股有Nanovibronix, Inc.、Pacific Biosciences Of California, Inc.、Nexalin Technology Inc C/Wts ，振幅分别为58.22%、42.23%、34.76%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215002035a246198c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215002035a246198c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508147531","title":"Rxsight, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508147531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508147531?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:10","pubTimestamp":1738595413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时10分，Rxsight, Inc.股票出现波动，股价大幅下跌5.08%。截至发稿，该股报32.15美元/股，成交量7.3913万股，换手率0.18%，振幅4.40%。Rxsight, Inc.股票所在的医疗器械行业中，整体跌幅为0.73%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231013abc10fe1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231013abc10fe1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXST","BK4198","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508995874","title":"Rxsight, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508995874","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508995874?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:53","pubTimestamp":1738346010,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日01时53分，Rxsight, Inc.股票出现波动，股价快速拉升5.08%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.54%。其相关个股中，Biosig Technologies, Inc.、Sensus Healthcare, Inc.、Helius Medical Technologies, Inc.涨幅较大，Nanovibronix, Inc.、Helius Medical Technologies, Inc.、Nuwellis, Inc.较为活跃，换手率分别为47.31%、10.45%、9.29%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Tenon Medical Inc C/Wts 16/06/2028 、Biosig Technologies, Inc.，振幅分别为77.88%、50.27%、24.30%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201015330987776d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201015330987776d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXST","BK4539","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503502091","title":"Rxsight, Inc.盘中异动 快速下跌5.11%报29.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503502091","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503502091?lang=zh_cn&edition=full","pubTime":"2025-01-15 01:56","pubTimestamp":1736877408,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日01时56分，Rxsight, Inc.股票出现波动，股价急速下挫5.11%。截至发稿，该股报29.15美元/股，成交量19.4014万股，换手率0.48%，振幅7.26%。Rxsight, Inc.股票所在的医疗器械行业中，整体跌幅为0.15%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115015648abaadada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250115015648abaadada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503532087","title":"富国银行：维持RxSight(RXST.US)评级，由持股观望调整至持股观望评级, 目标价由42.00美元调整至40.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503532087","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503532087?lang=zh_cn&edition=full","pubTime":"2025-01-14 03:31","pubTimestamp":1736796661,"startTime":"0","endTime":"0","summary":"富国银行：维持RxSight(RXST.US)评级，由持股观望调整至持股观望评级, 目标价由42.00美元调整至40.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/14033147410582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503645584","title":"Stifel：维持RxSight(RXST.US)评级，由持有调整至持有评级, 目标价由40.00美元调整至35.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2503645584","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503645584?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:55","pubTimestamp":1736783720,"startTime":"0","endTime":"0","summary":"Stifel：维持RxSight(RXST.US)评级，由持有调整至持有评级, 目标价由40.00美元调整至35.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/13235547403858.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["RXST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503917588","title":"Rxsight, Inc.盘中异动 早盘股价大跌5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503917588","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503917588?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:30","pubTimestamp":1736778638,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时30分，Rxsight, Inc.股票出现异动，股价急速跳水5.23%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，迪卡斯、Qt Imaging Holdings, Inc.、德康医疗涨幅较大，Reshape Lifesciences, Inc.、Catheter Precision, Inc.、Naya Biosciences, Inc.较为活跃，换手率分别为3.45%、3.07%、2.76%，振幅较大的相关个股有Butterfly Network, Inc.、Rxsight, Inc.、Nexalin Technology, Inc.，振幅分别为5.29%、2.66%、2.63%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132230399864d56d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132230399864d56d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492141440","title":"Rxsight, Inc.盘中异动 早盘大幅下跌7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492141440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492141440?lang=zh_cn&edition=full","pubTime":"2024-12-20 22:32","pubTimestamp":1734705137,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日22时32分，Rxsight, Inc.股票出现波动，股价大幅下挫7.57%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.20%。其相关个股中，Helius Medical Technologies, Inc.、Aethlon Medical, Inc.、Envoy Medical, Inc.涨幅较大，Helius Medical Technologies, Inc.、Aethlon Medical, Inc.、Bone Biologics Corp较为活跃，换手率分别为1536.98%、89.81%、7.04%，振幅较大的相关个股有Helius Medical Technologies, Inc.、Aethlon Medical, Inc.、Biosig Technologies, Inc.，振幅分别为60.40%、10.41%、10.00%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223218a1fe2411&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220223218a1fe2411&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RXST","BK4198","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492418736","title":"Rxsight, Inc.盘中异动 快速上涨5.01%报39.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492418736","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492418736?lang=zh_cn&edition=full","pubTime":"2024-12-17 03:42","pubTimestamp":1734378131,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日03时42分，Rxsight, Inc.股票出现波动，股价快速拉升5.01%。截至发稿，该股报39.17美元/股，成交量44.628万股，换手率1.11%，振幅5.95%。Rxsight, Inc.股票所在的医疗器械行业中，整体涨幅为0.04%。Rxsight, Inc.公司简介：RxSight Inc是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217034211ab7d19bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217034211ab7d19bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RXST","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rxsight.com","stockEarnings":[{"period":"1week","weight":0.0267},{"period":"1month","weight":0.0867},{"period":"3month","weight":-0.2514},{"period":"6month","weight":-0.4332},{"period":"1year","weight":-0.2576},{"period":"ytd","weight":-0.4827}],"compareEarnings":[{"period":"1week","weight":-0.0098},{"period":"1month","weight":0.0041},{"period":"3month","weight":0.055},{"period":"6month","weight":0.0844},{"period":"1year","weight":0.1885},{"period":"ytd","weight":0.096}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RxSight, Inc.于1997年3月5日在加利福尼亚州注册成立，并于2021年7月6日在特拉华州重新注册。该公司是一家商业阶段的医疗技术公司，致力于改善白内障手术后患者的视力。公司专有的RxSight可调光透镜系统，由公司的RxSight可调光透镜、RxSight投光装置及配件组成，是第一个也是唯一一个商用的人工晶状体技术，使医生能够为白内障手术后的患者定制和优化视力。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.0065},{"month":2,"riseRate":0.4,"avgChangeRate":0.036267},{"month":3,"riseRate":0.2,"avgChangeRate":-0.040536},{"month":4,"riseRate":0.6,"avgChangeRate":-0.038877},{"month":5,"riseRate":0.8,"avgChangeRate":0.077794},{"month":6,"riseRate":0.6,"avgChangeRate":-0.000771},{"month":7,"riseRate":0.6,"avgChangeRate":-0.060284},{"month":8,"riseRate":0.4,"avgChangeRate":0.012162},{"month":9,"riseRate":0,"avgChangeRate":-0.076907},{"month":10,"riseRate":0.4,"avgChangeRate":-0.044264},{"month":11,"riseRate":0.6,"avgChangeRate":0.103806},{"month":12,"riseRate":0.4,"avgChangeRate":0.00234}],"exchange":"NASDAQ","name":"RxSIGHT, INC.","nameEN":"RxSIGHT, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RxSIGHT, INC.(RXST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RxSIGHT, INC.(RXST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RxSIGHT, INC.,RXST,RxSIGHT, INC.股票,RxSIGHT, INC.股票老虎,RxSIGHT, INC.股票老虎国际,RxSIGHT, INC.行情,RxSIGHT, INC.股票行情,RxSIGHT, INC.股价,RxSIGHT, INC.股市,RxSIGHT, INC.股票价格,RxSIGHT, INC.股票交易,RxSIGHT, INC.股票购买,RxSIGHT, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RxSIGHT, INC.(RXST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RxSIGHT, INC.(RXST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}